The weight regain patterns observed with other agonists suggest that maintaining lifestyle changes during the treatment period is crucial for sustaining results after discontinuation
Improved lab markers : Beyond weight, we typically see improvements in inflammatory markers, cholesterol values, and liver function testsreducing long-term health risks
Improvement in endocrine and ovarian function during dietary treatment of obese women with polycystic ovary syndrome
It is not like a bottle of medication sitting in a medicine cabinet
Other examples of potential functional interactions might include the receptor for long-chain saturated fatty acids, FFA1, which is also expressed in pancreatic beta cells, where its activation leads to GSIS potentiation via G q transducer pathways (Secor et al., 2021) and enteroendocrine L and K cells, where it contributes to incretin hormone secretion, with FFA1 KO mice exhibiting obesity on a low-fat diet (Lu et al., 2021)
People with type 2 diabetes and a history of diabetic eye disease may need monitoring
